ARCH Venture Partners portfolio
96 tracked investments, 13 on the map, $3.8B raised across the mapped portfolio.
Xaira Therapeutics
Generate BiomedicinesSeries C
eGenesis
Aspen NeuroscienceSeries C
Seaport Therapeutics
Synchron
Mirador TherapeuticsSeries B
Encoded TherapeuticsSeries D- ADAmphora DiscoverySeries E
bit.bio
ParadigmKSQ TherapeuticsSeries C
Quantum Circuits
Also in the portfolio
- Alnylam Pharmaceuticals
- Kardigan
- Vizgen
- Elephas
- Altos Labs
- Lightcast Discovery
- Resilience
- Homeward
- Rapport Therapeutics
- Pretzel Therapeutics
- Treeline Biosciences
- Tenvie Therapeutics
- LifeMine Therapeutics
- Rippl Care
- Arbor Biotechnologies
- Be Biopharma
- Dewpoint Therapeutics
- Magnet Biomedicine
- Boundless Bio
- ArsenalBio
- Illumina
- AIRNA
- Chroma Medicine
- Accompany Health
- HI-Bio
- Volastra Therapeutics
- Aira
- City Therapeutics
- Cytrellis Biosystems
- Brii Biosciences
- Beam Therapeutics
- Denali Therapeutics
- Agios Pharmaceuticals
- HiberCell
- AgBiome
- Matter Neuroscience
- Genetix Biotherapeutics Inc.
- Paratus Sciences
- Protillion Biosciences
- Semma Therapeutics
- Fate Therapeutics
- Walden Biosciences
- Proof Diagnostics
- Karuna Therapeutics
- AmberWave
- Agrivida
- ONI
- Happy Health
- Cooledge Lighting
- LunaDNA
- Homology Medicines
- Omniome
- Bellerophon Therapeutics
- Adesto Technologies
- Nanophase Technologies
- PRIME Coalition
- Chiasma
- Sapphire Energy
- Cambrios Technologies
- Medvantx
- Classmates.com
- Allozyne
- Movidius
- Juno Therapeutics
- NextCODE Health
- Elixir Pharmaceuticals
- Apropos Technology
- NexCura
- Receptos
- Boreal Genomics
- Nura
- Xtera
- VBI Vaccines
- Appliant.com
- Xenoport
- Fast Track
- BIND Therapeutics
- GenVec
- MediaPhy
- New Era of Networks
- Accelerator Corp.